Unidoc Health Corp.
UDOCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $2 |
| SG&A Expenses | $6 | $2 | $1 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $2 | $1 | $3 |
| Operating Income | -$6 | -$2 | -$1 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$6 | -$2 | -$1 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$2 | -$1 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.062 | -0.27 |
| % Growth | 8.3% | -93.2% | 77% | – |
| EPS Diluted | -0.11 | -0.12 | -0.062 | -0.27 |
| Weighted Avg Shares Out | 56 | 50 | 22 | 11 |
| Weighted Avg Shares Out Dil | 56 | 50 | 22 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$2 | -$1 | -$3 |
| % Margin | – | – | – | – |